Literature DB >> 7257347

Mesothelioma: current perspectives.

R A Taylor, L P Johnson.   

Abstract

Thirty patients with the diagnosis of mesothelioma were admitted to the Swedish Hospital Medical Center, Seattle, from 1975 to 1979. Of these, 26 had pleural and 4 had peritoneal mesothelioma. In 20 of the patients with pleural mesothelioma, the diagnosis had been made by open thoractomy and in only one by needle biopsy of the pleura. The average survival of the patients with pleural tumors from time of diagnosis was 15 months, and two are alive at three and eight months, respectively, one of whom had an apparent solitary benign mesothelioma. The average survival of those with peritoneal mesothelioma was ten months, although one has survived six years. There were 17 patients with a known history of exposure to asbestos, 14 while working in shipyards. Because of the relatively high incidence of this previously rare tumor in the Puget Sound, Washington, area, and the generally dismal results of therapy, better methods of diagnosis including thoracoscopy and a more systematic approach to treatment are recommended.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7257347      PMCID: PMC1272760     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  23 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Asbestos and smoking.

Authors:  I J Selikoff; E C Hammond
Journal:  JAMA       Date:  1979-08-03       Impact factor: 56.272

3.  Mesothelioma following exposure to asbestos: a review of 72 cases.

Authors:  M Borow; A Conston; L Livornese; N Schalet
Journal:  Chest       Date:  1973-11       Impact factor: 9.410

4.  Solitary (localized) pleural mesothelioma. Report of two cases and review of the literature.

Authors:  F H Shabanah; S F Sayegh
Journal:  Chest       Date:  1971-12       Impact factor: 9.410

5.  Pleural mesotheliomas. Clinical experiences with thirty-seven patients.

Authors:  E R Ratzer; J L Pool; M R Melamed
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1967-04

6.  Pleural mesothelioma.

Authors:  H J Wanebo; N Martini; M R Melamed; B Hilaris; E J Beattie
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

7.  Mesothelioma and asbestos in the Province of Quebec, 1969-1972.

Authors:  G P Thériault; L Grand-Bois
Journal:  Arch Environ Health       Date:  1978 Jan-Feb

8.  Surgical management of malignant mesothelioma.

Authors:  G A DeLaria; R Jensik; L P Faber; C F Kittle
Journal:  Ann Thorac Surg       Date:  1978-10       Impact factor: 4.330

9.  Diffuse pulmonary malignant mesothelioma: response to doxorubicin and 5-azacytidine.

Authors:  A P Chahinian; Y Suzuki; E M Mandel; J F Holland
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

10.  The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma.

Authors:  B S Yap; R S Benjamin; M A Burgess; G P Bodey
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

View more
  2 in total

Review 1.  Diffuse malignant mesothelioma: a review.

Authors:  W N Rom; J E Lockey
Journal:  West J Med       Date:  1982-12

Review 2.  Peritoneal mesothelioma.

Authors:  R N Taub; M L Keohan; J C Chabot; K S Fountain; M Plitsas
Journal:  Curr Treat Options Oncol       Date:  2000-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.